Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001858808 | SCV002219124 | uncertain significance | Hypertrophic cardiomyopathy 14 | 2021-08-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MYH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 807075). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs767570086, ExAC 0.02%). This sequence change replaces serine with leucine at codon 1301 of the MYH6 protein (p.Ser1301Leu). The serine residue is weakly conserved and there is a large physicochemical difference between serine and leucine. |
Fulgent Genetics, |
RCV002497299 | SCV002787341 | uncertain significance | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2021-07-22 | criteria provided, single submitter | clinical testing |